Maze Therapeutics, Inc.

MAZE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$22.52-3.92%

2026-09-18

Financials

Valuation Metrics

Maze Therapeutics, Inc.'s Market Cap is $1.25B. At end of 2025 it was $1.78B. Ranked #2316 of 3,121 in US market (top 74%), #934 of 1,463 on NASDAQ (top 64%), #175 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 66%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.25B	US#2,316/3,121 Sec#175/266
Revenue	$20M	US#2,820/3,121 Sec#165/266
Net Income	$-134M	US—/3,121 Sec—/266
Total Assets	$532M	US#2,746/3,121 Sec#158/266
Net Assets	$453M	US#2,299/3,121 Sec#119/266
Value
P/B	2.75x	US#1,698/3,121 Sec#82/266
P/S	62.32x	US#2,931/3,121 Sec#169/266
FCF Yield	-8.57%	US—/3,121 Sec—/266
Profitability
ROE	-29.48%	US#2,564/3,121 Sec#112/266
ROA	-25.13%	US#2,852/3,121 Sec#143/266
Op. Margin	-728.06%	US#2,819/3,121 Sec#162/266
Revenue Growth	700.00%	US#27/3,121 Sec#14/266
Financial Health
Debt Ratio	17.32%	US#198/3,121 Sec#73/266
Total Debt	$60M	US#2,571/3,121 Sec#146/266
FCF	$-107M	US#2,641/3,121 Sec#148/266
Cash	$203M	US#1,730/3,121 Sec#108/266
Current Ratio	18.31x	US#129/3,121 Sec#31/266
Performance
1Y Return	-4.09%	US#1,820/3,121 Sec#183/266
1M Return	-24.30%	US#2,967/3,121 Sec#241/266
From 52W High	-58.02%	US#2,859/3,121 Sec#229/266
1Y MDD	-56.56%	US#2,627/3,121 Sec#199/266
Trading
Volume	1,220,095 shares	US#2,299/3,121 Sec#232/266
Trading Value	$28M	US#2,433/3,121 Sec#201/266
Per Share
EPS	$-2.41	US—/3,121 Sec—/266
BPS	$8.19	US#1,986/3,121 Sec#86/266